Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model.

Jiang Q, Xu P, Zhong H, Fu S, Wang L, Zhao W, Cheng S, Zha J, Xu B

DOI: 10.1186/s40364-026-00996-y
Published: 2026 Sep 16
Container: Biomarker research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00996-y,
  title = {Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model.},
  author = {Jiang Q and Xu P and Zhong H and Fu S and Wang L and Zhao W and Cheng S and Zha J and Xu B},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00996-y},
  url = {https://doi.org/10.1186/s40364-026-00996-y}
}

RIS

TY  - JOUR
TI  - Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model.
AU  - Jiang Q
AU  - Xu P
AU  - Zhong H
AU  - Fu S
AU  - Wang L
AU  - Zhao W
AU  - Cheng S
AU  - Zha J
AU  - Xu B
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00996-y
UR  - https://doi.org/10.1186/s40364-026-00996-y
ER  -

APA

Q, J., P, X., H, Z., S, F., L, W., W, Z., S, C., J, Z., & B, X. (2026). Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model.. Biomarker research. https://doi.org/10.1186/s40364-026-00996-y

Source records

pubmed · retrieved 2026-09-26T06:13:43.586Z